-
Notable Analyst Rating Changes 5/18: (TSLA) (EQR) (PLCE) Upgraded; (SNI) (XCOM) (ANAC) Downgraded
-
Notable Mergers and Acquisitions 5/16: (PFE)/(ANAC) (RRC)/(MRD) (LMNX)/(NSPH) (LECO) (EQIX)/(DLR)
-
Pfizer to buy Anacor in $5.2 billion deal for access to eczema gel
-
Pfizer (PFE) to Acquire Anacor Pharmaceuticals (ANAC) in $5.2B Deal
-
Pfizer to Acquire Anacor
-
Anacor Pharmaceuticals, Inc. Announces Pricing of Offering of $250 Million of 2.00% Convertible Senior Notes Due 2023
-
Citi Starts Anacor Pharmaceuticals (ANAC) at Buy
-
Anacor Pharmaceuticals (ANAC) IPO Trades Flat
-
Anacor Pharma (ANAC) Files $86.25M IPO

